Data / Drug companies / Sicor S.r.l.
Sicor S.r.l.: 53 products in the FDA NDC directory, labeler code 53183
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Sicor S.r.l. (labeler code 53183) lists 53 products in the FDA National Drug Code Directory. By type: 53 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on October 15, 2024.
The request: Watch Sicor S.r.l. (FDA labeler code 53183): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 53183
- Products in commercial distribution
- 53
- Packages
- 53
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- September 1, 2004
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 53 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 53 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 53 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Beclomethasone dipropionate anhydrous micronized w.s | 53183-5408 | Powder | Bulk ingredients | October 15, 2024 |
| Fluocinolone acetonide micro | 53183-8261 | Powder | Bulk ingredients | December 7, 2023 |
| Budesonide micronized | 53183-6309 | Powder | Bulk ingredients | October 16, 2023 |
| Difluprednate micronized | 53183-5376 | Powder | Bulk ingredients | November 22, 2019 |
| Mitomycin | 53183-7010 | Powder | Bulk ingredients | August 21, 2019 |
| Dm4 | 53183-4007 | Powder | Bulk ingredients | August 21, 2019 |
| Fluorometholone 17-acetate micronized | 53183-0538 | Powder | Bulk ingredients | August 21, 2019 |
| Betamethasone acetate micronized | 53183-0459 | Powder | Bulk ingredients | August 21, 2019 |
| Diflorasone diacetate micronized | 53183-0424 | Powder | Bulk ingredients | August 21, 2019 |
| Bleomycin sulfate | 53183-7003 | Powder | Bulk ingredients | August 13, 2019 |
| Daunorubicin hydrochloride | 53183-1447 | Powder | Bulk ingredients | August 13, 2019 |
| Deutetrabenazine | 53183-4062 | Powder | Bulk ingredients | June 17, 2019 |
| Fludarabine phosphate | 53183-7841 | Powder | Bulk ingredients | February 19, 2019 |
| Sunitinib malate | 53183-4012 | Powder | Bulk ingredients | March 26, 2018 |
| Epirubicin hydrochloride lyoph | 53183-7040 | Powder | Bulk ingredients | February 1, 2018 |
| Tipiracil hcl | 53183-9306 | Powder | Bulk ingredients | December 12, 2017 |
| Desoximetasone micronized | 53183-6762 | Powder | Bulk ingredients | December 7, 2017 |
| Cisatracurium besylate | 53183-4014 | Powder | Bulk ingredients | December 7, 2017 |
| Betamethasone valerate micr. | 53183-0456 | Powder | Bulk ingredients | November 21, 2017 |
| Clobetasol propionate micronized | 53183-0446 | Powder | Bulk ingredients | November 21, 2017 |
| Betamethasone dipropionate micr | 53183-0433 | Powder | Bulk ingredients | November 21, 2017 |
| Fluocinonide micronized | 53183-0260 | Powder | Bulk ingredients | November 21, 2017 |
| Triamcinolone acetonide micron | 53183-0120 | Powder | Bulk ingredients | November 21, 2017 |
| Doxorubicin hydrochloride | 53183-7000 | Powder | Bulk ingredients | April 3, 2017 |
| Fluorometholone micronized | 53183-0530 | Powder | Bulk ingredients | March 13, 2017 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.